Response from Dr. Sherer

When you have a persistently detectable viral load that is rising, as you have had, that meets the definition for virologic failure.
The proper course at that time is to obtain a resistance test and to switch the entire regimen to a second line regimen with three active drugs, one of which is a new class of drugs.
The only setting in which a dose escalation has been shown to be of some (limited) use is in trials in which a drug level has been done that shows an inadequately low blood level that is then corrected with the increased dose. Unfortunately, this is NOT well described for regimens containing Sustiva, and I would not endorse this course of action. It is possible that there are other aspects of your case that I am unaware of that have led your doctor to this course of action, based on a drug level of Sustiva, but it would be an unusual situation.
It is certainly possible for an individual who has maintained excellent adherence, as you have described, to develop virologic failure on a Sustiva-containing regimen. As above, when that happens, the best course is to promptly obtain a resistance test (after confirming true virologic failure) and to switch to a new three drug regimen with at least one new class of drugs, most likely in your case to include a boosted PI.
I suggest that you take this email response and your questions and concerns back to your doctor. It may also be wise to seek a second opinion.
If you would like a reference for the diagnosis and optimal management of virologic failure and resistance testing, I refer you to the updated HHS Guidelines of January, 2008, pgs 32-41, at http://AIDSinfo.nih.gov.
|